However, potential therapeutic methods targeting various pathogenic pathways in tauopathies include the suppression of MAPT expression, regulation of alternative splicing, stabilization of microtubules, regulation of post-translational modifications, inhibition of aggregation, activation of tau clearance, and the use of passive or active immunization. The gene discussed is MAPT; the disease is tauopathy.